Company intelligence / Profile preview

InStride

Boston, Massachusetts, United States

Ownership: Private
Development stage: Other

Overview

InStride Health delivers insurance-based, evidence-driven outpatient care for pediatric anxiety and OCD, offering rapid access (1-4 weeks), team-based treatment, and measurable improvements in anxiety, functional impairment, and depression, with large effect sizes comparable to leading academic centers

Therapeutic areas: Psychiatry
Modalities: Non-pharmacological therapy (Cognitive Behavioral Therapy)Acceptance and Commitment TherapyExposure and Response Prevention
Industry: Non-Academic Healthcare

Partnerships

Mass General Brigham Venturescollaborative relationships with McLean Hospitalschoolsregional physicians

Beyond the preview

Go deeper on InStride.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on InStride.

Explore the full profile